HDGFL2 and malaria: The RDT kit used in the present study targets P. falciparum specific histidine-rich protein 2 (HRP2), which may persist in the blood for a few weeks after treatments.63,64 In high malaria transmission areas, frequent reinfections and treatments increase RDT false positives.